Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

SBC Medical Group Holdings (SBC) Loans and Notes Receivables (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Loans and Notes Receivables for 3 consecutive years, with $3.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Loans and Notes Receivables fell 0.93% year-over-year to $3.1 million, compared with a TTM value of $3.1 million through Sep 2025, down 0.93%, and an annual FY2024 reading of $3.1 million, up 2.01% over the prior year.
  • Loans and Notes Receivables was $3.1 million for Q3 2025 at SBC Medical Group Holdings, roughly flat from $3.1 million in the prior quarter.
  • Across five years, Loans and Notes Receivables topped out at $3.1 million in Q1 2025 and bottomed at $3.1 million in Q4 2023.
  • Average Loans and Notes Receivables over 3 years is $3.1 million, with a median of $3.1 million recorded in 2024.
  • The sharpest move saw Loans and Notes Receivables grew 2.01% in 2024, then decreased 0.93% in 2025.
  • Year by year, Loans and Notes Receivables stood at $3.1 million in 2023, then grew by 2.01% to $3.1 million in 2024, then dropped by 1.58% to $3.1 million in 2025.
  • Business Quant data shows Loans and Notes Receivables for SBC at $3.1 million in Q3 2025, $3.1 million in Q2 2025, and $3.1 million in Q1 2025.